Table 1.
Patient | Sex | Age | Sepsis etiology | SAPS II | SOFA | Norepinephrine HO µg/min/kg | Timing norepinephrine-esmolol introduction (hours) |
---|---|---|---|---|---|---|---|
1 | F | 82 | Infectious pneumonia | 79 | 12 | 2.00 | 8 |
2 | H | 58 | Candidemia | 61 | 14 | 0.57 | 9 |
3 | H | 54 | Colo-pericardial fistulae | 72 | 7 | 0.44 | 8 |
4 | F | 65 | Infectious pneumonia | 26 | 8 | 0.20 | 11 |
5 | F | 59 | Ascitis | 66 | 14 | 0.91 | 10 |
6 | H | 71 | Soft skin | 139 | 16 | 0.66 | 12 |
7 | H | 61 | Infectious pneumonia | 66 | 9 | 0,13 | 4 |
8 | F | 83 | Biliary tract infection | 73 | 14 | 0.83 | 5 |
9 | F | 24 | Peritonitis | 58 | 8 | 0.49 | 13 |
SAPS II Simplified Acute Physiology II Score, SOFA Sequential Organ Failure Assessment, HO O hours (baseline)